Gabapentin and Tekturna drug interactions for women aged 60+ (a phase IV clinical study of FDA data)
Summary:
Drug interactions are found for women aged 60+ who take Gabapentin (gabapentin) and Tekturna (aliskiren hemifumarate) together. We list drug interactions by the duration when the drugs are taken. This phase IV study is created by eHealthMe based on reports of 34 people from the FDA, and is updated regularly.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
34 women aged 60+ who take Gabapentin, Tekturna and have drug interactions are studied.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.
What is Tekturna?
Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.
Number of reports submitted per year:
Most common drug interactions over time *:
< 1 month:
- Dyspnoea (difficult or laboured respiration)
- Iliotibial band syndrome (injury to the thigh)
- Malaise (a feeling of general discomfort or uneasiness)
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
- Iliotibial band syndrome (injury to the thigh)
- Malaise (a feeling of general discomfort or uneasiness)
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
- Peripheral swelling
- Anxiety
- Application site pain
- Back disorder
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Drug hypersensitivity
- Dyspnoea (difficult or laboured respiration)
- Flushing (the warm, red condition of human skin)
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and Tekturna?
- Personalize this study to your gender, age, symptoms and drugs- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, gabapentin and aliskiren hemifumarate (the active ingredients of Gabapentin and Tekturna, respectively), and Gabapentin and Tekturna (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Novantrone cause Chest Pain? - 8 seconds ago
- Could Furosemide cause Cardiac Failure Aggravated? - 11 seconds ago
- Nasal Congestion and drugs of ingredients of acetaminophen; tramadol hydrochloride - 15 seconds ago
- Drug interactions of Alendronate Sodium and Dexamethasone Sodium Phosphate - 17 seconds ago
- Drug interactions of Vitamin B12 and Marshmallow - 26 seconds ago
- Drug interactions of Meclizine Hydrochloride and Profen - 27 seconds ago
- Could Triazolam cause Abdominal Distension? - 27 seconds ago
- Drug interactions of Estrone and Vitamin B12 - 27 seconds ago
- Could Ciprofloxacin Hydrochloride cause Hyponatremia? - 29 seconds ago
- Metronidazole and Speech Impairment (Adult) for Men aged 60+ - 30 seconds ago